Diamod®: A unique in vitro technology platform to study the gastrointestinal performance of oral dosage forms 

In vivo predictive in vitro models are indispensable tools to evaluate the gastrointestinal behavior of oral dosage forms thereby accelerating the formulation development process and de-risking drug development projects. This is especially the case for drugs with poor aqueous solubility (BCS class II) for which intensive bio-enabling formulation development is required already during early stages of product development.